naltrexone has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joukar, S; Najafipour, H; Rostamzadeh, F; Yeganeh-Hajahmadi, M | 1 |
| Dehpour, AR; Deroee, AF; Hosseini, R; Jahanzad, I; Mehr, SE; Nezami, BG; Salmasi, AH; Talab, SS | 1 |
| Williams, A | 1 |
3 other study(ies) available for naltrexone and Kidney Diseases
| Article | Year |
|---|---|
Opioid receptors mediate inotropic and depressor effects of apelin in rats with 2K1C-induced chronic renovascular hypertension.
Topics: Animals; Apelin; Blood Pressure; Gene Expression Regulation; Hypertension; Intercellular Signaling Peptides and Proteins; Kidney Diseases; Male; Myocardial Contraction; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid | 2018 |
Cholestasis induced nephrotoxicity: the role of endogenous opioids.
Topics: Acetylglucosaminidase; Analgesics, Opioid; Animals; Bilirubin; Cholestasis; Enzyme Activation; Kidney; Kidney Diseases; Liver; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley | 2010 |
Primary care of parenteral substance abusers.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intranasal; Antibodies, Viral; Body Weight; Cocaine; Female; Heart Diseases; Hepatitis; Heroin Dependence; HIV Antibodies; Humans; Injections, Intradermal; Injections, Intravenous; Kidney Diseases; Male; Menstruation Disturbances; Methadone; Naltrexone; Nervous System Diseases; Primary Health Care; Respiratory Tract Diseases; Substance-Related Disorders | 1986 |